glp-1 antagonists receptor agonists show promise in treating substance use disorders Mechanisms of GLP-1 Receptor Agonist-Induced
Description
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: a replication study using reports to the World Health Organization pharmacovigilance database (VigiBase)
2025;17:e96218
24 These effects result from several interrelated mechanisms, including improvements in insulin sensitivity, reductions in sympathetic activity, decreased plasma volume, and favorable changes in vascular function, many of which overlap with the direct pathways described above
264 , E606E613 (1993)
